About: Voyager Therapeutics, Inc., a biotechnology company, focuses on the human genetics for the cure of neurological diseases. Its product pipeline includes VY1706, a tau silencing gene therapy and VY7523, an anti-tau antibody program for the treatment of alzheimer's disease. The company also provides research program for the treatment of Huntington's disease. In addition, it offers TRACER, an adeno-associated virus (AAV) capsid discovery platform; ALPL-VYGR-NeuroShuttle, to target an undisclosed neurological disease; and develops selective small molecules for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia with TDP-43 pathology. The company has collaboration and license agreements with Alexion; AstraZeneca Ireland Limited; Novartis Pharma AG; and Transition Bio, Inc. for the treatment of various other diseases of the central nervous system. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.84 (+6.36%)
VYGR NASDAQ Voyager Therapeutics Inc
Voyager Therapeutics Inc share price
Atividade de preço de VYGR
Último preço
$ 1,850
Variação (24h)
0,12 USD (6,94%)
Volume
1.13M
Volume (média 4 sem.)
-
Abertura
$ 1,72
Variação do dia
$ 1,70 - $ 1,85
Fechamento anterior
$ 1,73
Último negócio
28 Oct, 8:06 pm GMT+0
Atrasado
28 Oct, 8:06 pm GMT+0
VYGR price performance
Atrasado
28 Oct, 8:06 pm GMT+0
quote.marketSignals